Breaking News Instant updates and real-time market news.

ALDX

Aldeyra

$3.58 /

-0.025 (-0.69%)

14:07
06/08/22
06/08
14:07
06/08/22
14:07

Alliance Global says Aldeyra trading may be due to regulatory uncertainty

Alliance Global Partners analyst Matt Cross said Aldeyra announced a successful conclusion to the TRANQUILITY-2 study and now expects to submit data to the FDA from five reproxalap DED trials as part of its NDA submission in this indication. However, despite what he calls "the good news," the stock has traded flat to slightly down in today's session, which he would speculate is due to investor uncertainty on "final regulatory checkboxes" and commercial preparedness or partnering. Cross, who contends that today's data "emphasize the asset's attractiveness substantially," keeps a Buy rating and $24 price target on Aldeyra shares, which are up 1% to $3.63 in afternoon trading.

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
uniQure to hold a virtual event » 22:49
11/28/22
11/28
22:49
11/28/22
22:49
QURE

uniQure

$27.32 /

+0.42 (+1.56%)

Virtual Research &…

Virtual Research & Development Event to be held on November 29 at 8:30 am. Webcast Link

ShowHide Related Items >><<
QURE uniQure
$27.32 /

+0.42 (+1.56%)

QURE uniQure
$27.32 /

+0.42 (+1.56%)

11/23/22 Piper Sandler
FDA 'tea leaves' bode well for BioMarin's Roctavian, says Piper Sandler
11/23/22 Truist
uniQure price target raised to $65 from $51 at Truist
08/09/22 Wells Fargo
uniQure price target lowered to $24 from $34 at Wells Fargo
08/09/22 H.C. Wainwright
uniQure selloff brings attractive entry point, says H.C. Wainwright
QURE uniQure
$27.32 /

+0.42 (+1.56%)

QURE uniQure
$27.32 /

+0.42 (+1.56%)

Downgrade
CinCor Pharma downgraded to Perform from Outperform at Oppenheimer » 21:03
11/28/22
11/28
21:03
11/28/22
21:03
CINC

CinCor Pharma

$14.20 /

-12.31 (-46.44%)

Oppenheimer analyst Jay…

Oppenheimer analyst Jay Olson downgraded CinCor Pharma to Perform from Outperform without a price target.

ShowHide Related Items >><<
CINC CinCor Pharma
$14.20 /

-12.31 (-46.44%)

CINC CinCor Pharma
$14.20 /

-12.31 (-46.44%)

11/28/22 Piper Sandler
CinCor Pharma price target lowered to $53 from $73 at Piper Sandler
10/28/22 Goldman Sachs
CinCor Pharma initiated with a Buy at Goldman Sachs
09/26/22
CinCor Pharma initiated with an Outperform at LifeSci Capital
08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
CINC CinCor Pharma
$14.20 /

-12.31 (-46.44%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$14.20 /

-12.31 (-46.44%)

CINC CinCor Pharma
$14.20 /

-12.31 (-46.44%)

Periodicals
Tyler Perry agrees to four-movie deal with Amazon, THR reports » 19:59
11/28/22
11/28
19:59
11/28/22
19:59
AMZN

Amazon.com

$93.99 /

+0.51 (+0.55%)

Filmmaker Tyler Perry has…

Filmmaker Tyler Perry has signed a four-movie deal with Amazon Prime Video, The Hollywood Reporter's Mia Galuppo reports. Under the pact, Perry will write, direct, and produce four feature films that will be released on the ecommerce giant's Prime Video service, the author notes. Reference Link

ShowHide Related Items >><<
AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

11/22/22 Piper Sandler
Amazon.com price target lowered to $119 from $125 at Piper Sandler
11/21/22 JPMorgan
JPMorgan more cautious on online holiday sales, Amazon still top idea
11/18/22 Erste Group
Amazon.com downgraded to Hold from Buy at Erste Group
11/15/22 MoffettNathanson
Amazon.com initiated with an Outperform at MoffettNathanson
AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

AMZN Amazon.com
$93.99 /

+0.51 (+0.55%)

Earnings
Joyy sees Q4 revenue $594M-$619M, consensus $628.4M  19:13
11/28/22
11/28
19:13
11/28/22
19:13
YY

Joyy

$27.51 /

+0.33 (+1.21%)

 
ShowHide Related Items >><<
YY Joyy
$27.51 /

+0.33 (+1.21%)

08/31/22 Benchmark
Benchmark calls Joyy 'attractive cash play for investors'
06/02/22 Daiwa
Joyy share downside is limited, says Daiwa
06/01/22 Morgan Stanley
Joyy downgraded to Equal Weight on limited visibility at Morgan Stanley
06/01/22 Morgan Stanley
Joyy downgraded to Equal Weight from Overweight at Morgan Stanley
YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

Earnings
Joyy reports Q3 revenue $586.7M, consensus $607.98M » 19:12
11/28/22
11/28
19:12
11/28/22
19:12
YY

Joyy

$27.51 /

+0.33 (+1.21%)

Average mobile MAUs of…

Average mobile MAUs of Bigo Live increased by 14.2% to 35.4 million from 31.0 million in the corresponding period of 2021. Average mobile MAUs of Likee decreased by 34.1% to 50.6 million from 76.8 million in the corresponding period of 2021, primarily due to reduced spending on user acquisition via advertisement. Average mobile MAUs of Hago decreased by 29.6% to 7.6 million from 10.8 million in the corresponding period of 2021, primarily due to reduced spending on user acquisition via advertisement. Global average mobile MAUs decreased by 6.6% to 269.8 million from 288.8 million in the corresponding period of 2021, primarily due to the decrease in average mobile MAUs of Likee and Hago.

ShowHide Related Items >><<
YY Joyy
$27.51 /

+0.33 (+1.21%)

08/31/22 Benchmark
Benchmark calls Joyy 'attractive cash play for investors'
06/02/22 Daiwa
Joyy share downside is limited, says Daiwa
06/01/22 Morgan Stanley
Joyy downgraded to Equal Weight on limited visibility at Morgan Stanley
06/01/22 Morgan Stanley
Joyy downgraded to Equal Weight from Overweight at Morgan Stanley
YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

YY Joyy
$27.51 /

+0.33 (+1.21%)

Periodicals
South Korea's Yoon tells Reuters country to offer 'tailored' incentives to Tesla » 19:09
11/28/22
11/28
19:09
11/28/22
19:09
TSLA

Tesla

$182.97 /

+0.01 (+0.01%)

South Korea president…

South Korea president Yoon Suk-yeol told Reuters that the country plans to offer "tailored" incentives to encourage Tesla to establish an electric vehicle gigafactory in South Korea and will minimize any risks presented by unions. The president held a video call with Tesla CEO Elon Musk last week, and the office cited Musk as saying the country is among the top candidates for a new gigafactory. "If Tesla, Space X or other companies are considering more investment in Korea including constructing a gigafactory, the government will do our best to support the investment," Yoon told Reuters during a broader interview in his office. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$182.97 /

+0.01 (+0.01%)

TSLA Tesla
$182.97 /

+0.01 (+0.01%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
11/23/22 Citi
Tesla upgraded to Neutral from Sell at Citi
11/10/22 Wedbush
Tesla removed from 'Best Ideas' list at Wedbush
TSLA Tesla
$182.97 /

+0.01 (+0.01%)

TSLA Tesla
$182.97 /

+0.01 (+0.01%)

TSLA Tesla
$182.97 /

+0.01 (+0.01%)

TSLA Tesla
$182.97 /

+0.01 (+0.01%)

Hot Stocks
Starbucks exec Conway sells 15,320 common shares » 19:05
11/28/22
11/28
19:05
11/28/22
19:05
SBUX

Starbucks

$98.67 /

-0.86 (-0.86%)

In a regulatory filing,…

In a regulatory filing, Starbucks International group president Michael Aaron Conway disclosed the sale of 15,320 common shares of the company on November 23 at a price of $99.139 per share.

ShowHide Related Items >><<
SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

11/04/22 Evercore ISI
Starbucks price target raised to $97 from $95 at Evercore ISI
11/04/22 Citi
Starbucks price target raised to $93 from $90 at Citi
11/04/22 Wedbush
Starbucks price target raised to $96 from $92 at Wedbush
11/02/22 Craig-Hallum
Cardlytics price target lowered to $7 from $15 at Craig-Hallum
SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

SBUX Starbucks
$98.67 /

-0.86 (-0.86%)

Hot Stocks
Durect announces 1-for-10 reverse stock split » 18:49
11/28/22
11/28
18:49
11/28/22
18:49
DRRX

Durect

/

+

Durect Corporation…

Durect Corporation announced that DURECT's board of directors today determined that the Company will effect a reverse stock split at a ratio of 1-for-10 as of 5:01 p.m. Eastern Time on December 5, 2022. Beginning with the opening of trading on December 6, 2022, the Company's common stock will trade on a split-adjusted basis. At a Special Meeting of Stockholders held on November 22, 2022, DURECT stockholders voted to approve a proposal authorizing the board of directors of the Company to amend the Company's certificate of incorporation to effect a reverse stock split of DURECT's outstanding common shares at an exchange ratio of not less than 1-for-10 and not greater than 1-for-20, and a reduction in the number of authorized shares of common stock from 600,000,000 to 150,000,000 shares. The reduction in the authorized number of shares will also be effective as of 5:00 p.m. Eastern Time on December 5, 2022.

ShowHide Related Items >><<
DRRX Durect
/

+

DRRX Durect
/

+

03/08/22 H.C. Wainwright
H.C. Wainwright keeps $6 target on Durect after Q4 results
03/04/22 H.C. Wainwright
Durect CFO exit does not impact positive thesis, says H.C. Wainwright
12/23/21 H.C. Wainwright
Durect found 'ideal partner' in Innocoll, says H.C. Wainwright
DRRX Durect
/

+

Periodicals
U.K. physical game sales on Black Friday fall 15% y/y, GI.biz reports » 18:42
11/28/22
11/28
18:42
11/28/22
18:42
EA

Electronic Arts

$128.45 /

-1.1 (-0.85%)

, ATVI

Activision Blizzard

$74.73 /

+1.21 (+1.65%)

, NTDOY

Nintendo

$10.54 /

-0.09 (-0.85%)

, SONY

Sony

$82.19 /

-0.81 (-0.98%)

, SGAMY

Sega Sammy Holdings

$3.27 /

-0.13 (-3.82%)

Physical video game sales…

Physical video game sales in the U.K. during this year's Black Friday week were 15% lower than during the same period last year, Gamesindustry.biz's Christopher Dring reports, citing GfK data. Software sales over the period have been declining in recent years, with last year's Black Friday sales having fallen 10% year-over-year, the author notes. The best-selling boxed game of the Black Friday period in the U.K. was EA's (EA) "FIFA 23," with Activision's (ATVI) "Call of Duty: Modern Warfare II" in second place and Nintendo's (NTDOY) "Pokemon Violet" in third, the author says. Other top-selling games during Black Friday in the U.K. were "Mario Kart 8 Deluxe," Sony's (SONY) "God of War Ragnarok," and Sega's (SGAMY) "Sonic Frontiers." Reference Link

ShowHide Related Items >><<
SONY Sony
$82.19 /

-0.81 (-0.98%)

SGAMY Sega Sammy Holdings
$3.27 /

-0.13 (-3.82%)

NTDOY Nintendo
$10.54 /

-0.09 (-0.85%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

11/28/22 Truist
Electronic Arts price target lowered to $150 from $154 at Truist
11/22/22 Truist
EA's Sports College Football timeline 'consistent' with model, says Truist
11/08/22 Deutsche Bank
Electronic Arts remains top pick in video games at Deutsche Bank
11/02/22 Wedbush
Electronic Arts price target lowered to $164 from $170 at Wedbush
ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

11/28/22 JPMorgan
Activision Blizzard price target lowered to $86 from $95 at JPMorgan
11/28/22 Wells Fargo
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
11/28/22 Morgan Stanley
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley
11/28/22 Truist
Activision Blizzard upgraded to Buy from Hold at Truist
NTDOY Nintendo
$10.54 /

-0.09 (-0.85%)

09/07/22 Goldman Sachs
Nintendo resumed with a Buy at Goldman Sachs
05/24/22 CLSA
Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA
03/23/22 Macquarie
Nintendo upgraded to Outperform from Neutral at Macquarie
02/16/22 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
SONY Sony
$82.19 /

-0.81 (-0.98%)

11/02/22 Cowen
Sony price target lowered to $102 from $144 at Cowen
10/13/22 Oppenheimer
Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
09/07/22 Goldman Sachs
Sony resumed with a Neutral at Goldman Sachs
07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
SGAMY Sega Sammy Holdings
$3.27 /

-0.13 (-3.82%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

NTDOY Nintendo
$10.54 /

-0.09 (-0.85%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

SGAMY Sega Sammy Holdings
$3.27 /

-0.13 (-3.82%)

NTDOY Nintendo
$10.54 /

-0.09 (-0.85%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

SGAMY Sega Sammy Holdings
$3.27 /

-0.13 (-3.82%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

EA Electronic Arts
$128.45 /

-1.1 (-0.85%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

Hot Stocks
Faraday Future names Xuefeng Chen global CEO » 18:29
11/28/22
11/28
18:29
11/28/22
18:29
FFIE

Faraday Future

/

+

Faraday Future…

Faraday Future Intelligent Electric announced that the FFIE Board of Directors has appointed FF China CEO Xuefeng Chen as Global CEO of Faraday Future, effective immediately. Chen replaces Carsten Breitfeld, who was removed as Global CEO by the FFIE Board of Directors following a comprehensive evaluation of the Company's performance since it went public in July 2021. Pursuant to the Company's Corporate Governance Guidelines, management directors are required to tender their resignation from the Board upon their removal as an officer of the Company. The Board has requested that Mr. Breitfeld tender his resignation from the Board in accordance with such Corporate Governance Guidelines. As Global CEO, Chen is tasked with delivering the FF 91 Futurist to market, delivering on the promise made to FF stockholders, investors, global partners, users and employees. "I believe the decision to appoint XF at this critical juncture of the Company is a timely and correct one," said FFIE Chairman of the Board of Directors Adam He. "XF is a top talent in the global automotive industry and possesses both a global perspective and extensive hands-on experience across the global automotive industrial chain. His years of experience at Ford and Jaguar Land Rover will pave a solid foundation for his leadership of Faraday Future's global team. The Company's top priority right now is to deliver the FF 91 Futurist to our users with high quality and minimal cost, and to successfully realize the US-China dual home market strategy with the ultimate goal to maximize Faraday Future stockholder interest," added He.

ShowHide Related Items >><<
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

08/16/22 Benchmark
Faraday Future downgraded to Speculative Hold from Buy at Benchmark
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

On The Fly
Fly Intel: After-Hours Movers » 18:27
11/28/22
11/28
18:27
11/28/22
18:27
KALA

Kala Pharmaceuticals

$5.59 /

-0.12 (-2.10%)

, NXST

Nexstar

$174.69 /

-1.6 (-0.91%)

, SABR

Sabre

$5.45 /

+0.11 (+2.06%)

, AZEK

Azek

$17.45 /

-1.12 (-6.03%)

, SI

Silvergate Capital

$25.90 /

-3.19 (-10.97%)

Check out this evening's…

ShowHide Related Items >><<
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

KALA Kala Pharmaceuticals
$5.59 /

-0.12 (-2.10%)

AZEK Azek
$17.45 /

-1.12 (-6.03%)

KALA Kala Pharmaceuticals
$5.59 /

-0.12 (-2.10%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
NXST Nexstar
$174.69 /

-1.6 (-0.91%)

11/11/22 Barrington
Nexstar price target lowered to $200 from $240 at Barrington
11/09/22 Wells Fargo
Nexstar downgraded to Equal Weight from Overweight at Wells Fargo
10/06/22
Nexstar participates in a conference call with Benchmark
09/06/22 Rosenblatt
Nexstar upgraded to Buy from Neutral at Rosenblatt
SABR Sabre
$5.45 /

+0.11 (+2.06%)

10/17/22 Mizuho
Sabre price target lowered to $6 from $7 at Mizuho
09/28/22 Redburn
Sabre initiated with a Buy at Redburn
09/08/22 Mizuho
Sabre price target lowered to $7 from $8 at Mizuho
08/22/22 Mizuho
Sabre price target raised to $8 from $7 at Mizuho
AZEK Azek
$17.45 /

-1.12 (-6.03%)

10/20/22 Deutsche Bank
Azek price target lowered to $24 from $29 at Deutsche Bank
10/18/22 BofA
Azek price target lowered to $21 from $23 at BofA
10/14/22 Credit Suisse
Azek downgraded to Neutral from Outperform at Credit Suisse
10/10/22 Citi
Azek price target lowered to $22 from $24 at Citi
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
11/21/22 Craig-Hallum
Silvergate Capital price target lowered to $36 from $100 at Craig-Hallum
11/21/22 JPMorgan
Silvergate Capital price target lowered to $50 from $80 at JPMorgan
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

KALA Kala Pharmaceuticals
$5.59 /

-0.12 (-2.10%)

AZEK Azek
$17.45 /

-1.12 (-6.03%)

  • 07
    Dec
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

KALA Kala Pharmaceuticals
$5.59 /

-0.12 (-2.10%)

AZEK Azek
$17.45 /

-1.12 (-6.03%)

SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

Hot Stocks
Silvergate Capital says BlockFi deposit relationship limited to less than $20M » 17:55
11/28/22
11/28
17:55
11/28/22
17:55
SI

Silvergate Capital

$25.90 /

-3.19 (-10.97%)

Silvergate Capital…

Silvergate Capital announced a business update, citing that its deposit relationship with BlockFi Inc. is limited to less than $20M of its total deposits from all digital asset customers as of November 28, 2022. BlockFi is not a custodian for Silvergate's bitcoin-collateralized SEN Leverage loans, which to date have continued to perform as expected with zero losses and no forced liquidations. Silvergate has no investments in BlockFi. ilvergate maintains a first priority lien and security interest in a cash collateral account, which contains $10Mfor the benefit of Silvergate to support ACH services provided to BlockFi. "As the digital asset industry continues to transform, I want to reiterate that Silvergate's platform was purpose-built to manage stress and volatility," said Alan Lane, Chief Executive Officer of Silvergate. "The SEN continues to operate as designed, and our support teams are available 24 hours a day, 7 days a week to help our customers during this period of adversity."

ShowHide Related Items >><<
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
11/21/22 Craig-Hallum
Silvergate Capital price target lowered to $36 from $100 at Craig-Hallum
11/21/22 JPMorgan
Silvergate Capital price target lowered to $50 from $80 at JPMorgan
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

  • 07
    Dec
SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

SI Silvergate Capital
$25.90 /

-3.19 (-10.97%)

Hot Stocks
GE Healthcare, MediView partner over AR solutions for medical imaging » 17:53
11/28/22
11/28
17:53
11/28/22
17:53
GE

General Electric

$85.48 /

-2.3 (-2.62%)

GE Healthcare and…

GE Healthcare and MediView XR announced their collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR Interventional Suite System. MediView's current technology platform leverages spatial computing and mixed reality, united with medical imaging in combining augmented reality visualization, seamless remote collaboration and evidence-based clinical insights. "We are thrilled to advance our strategic collaboration with GE Healthcare by co-developing and creating the interventional suite of the future - one that is designed to improve ergonomics, with natural interactions for optimized workflow and facilitates care team collaboration. The physician is empowered to simultaneously interface with virtual monitors, holographic 3D anatomy, and remotely collaborate with colleagues around the world," said Mina Fahim, President and CEO of MediView. "Utilizing GE Healthcare's exceptional imaging and MediView's expertise in real-time augmented reality visualization and navigation, we're proud to together launch one of the largest deployments of augmented reality in healthcare to-date and grow clinical adoption of innovative extended reality solutions." GE Healthcare and MediView will co-market the solution and will explore opportunities for joint go-to-market efforts, with an initial market launch in the US and global expansion planned for the future.

ShowHide Related Items >><<
GE General Electric
$85.48 /

-2.3 (-2.62%)

GE General Electric
$85.48 /

-2.3 (-2.62%)

11/22/22 Northland
Hyliion Holdings initiated with an Outperform at Northland
11/11/22 UBS
General Electric price target raised to $98 from $79 at UBS
10/27/22 Morgan Stanley
General Electric price target raised to $88 from $85 at Morgan Stanley
10/26/22 RBC Capital
General Electric price target raised to $93 from $81 at RBC Capital
GE General Electric
$85.48 /

-2.3 (-2.62%)

GE General Electric
$85.48 /

-2.3 (-2.62%)

GE General Electric
$85.48 /

-2.3 (-2.62%)

GE General Electric
$85.48 /

-2.3 (-2.62%)

Periodicals
Microsoft to likely offer EU remedies in Activision takeover, Reuters says » 17:47
11/28/22
11/28
17:47
11/28/22
17:47
MSFT

Microsoft

$241.77 /

-5.8301 (-2.35%)

, ATVI

Activision Blizzard

$74.73 /

+1.21 (+1.65%)

, SONY

Sony

$82.19 /

-0.81 (-0.98%)

Microsoft (MSFT) will…

Microsoft (MSFT) will likely offer concessions to EU antitrust regulators in the coming weeks to ward off formal objections to its proposed $69B takeover of Activision Blizzard (ATVI), Reuters' Foo Yun Chee reports, citing people familiar with the matter. Such proposed remedies will consist mainly of a 10-year "Call of Duty" licensing deal with Sony (SONY), the author notes. Reference Link

ShowHide Related Items >><<
SONY Sony
$82.19 /

-0.81 (-0.98%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

11/28/22 JPMorgan
Activision Blizzard price target lowered to $86 from $95 at JPMorgan
11/28/22 Wells Fargo
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
11/28/22 Morgan Stanley
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley
11/28/22 Truist
Activision Blizzard upgraded to Buy from Hold at Truist
ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

11/02/22 Cowen
Sony price target lowered to $102 from $144 at Cowen
10/13/22 Oppenheimer
Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
09/07/22 Goldman Sachs
Sony resumed with a Neutral at Goldman Sachs
07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
SONY Sony
$82.19 /

-0.81 (-0.98%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

SONY Sony
$82.19 /

-0.81 (-0.98%)

MSFT Microsoft
$241.77 /

-5.8301 (-2.35%)

ATVI Activision Blizzard
$74.73 /

+1.21 (+1.65%)

Conference/Events
Knowles to host conference call » 17:35
11/28/22
11/28
17:35
11/28/22
17:35
KN

Knowles

$14.67 /

-0.44 (-2.91%)

President & CEO Niew…

President & CEO Niew and CFO Anderson hold a conference call to review the company's business segments, growth strategies, end markets and capital allocation framework on November 29 at 11 am. Webcast Link

ShowHide Related Items >><<
KN Knowles
$14.67 /

-0.44 (-2.91%)

KN Knowles
$14.67 /

-0.44 (-2.91%)

08/03/22 Roth Capital
Knowles downgraded to Neutral from Buy at Roth Capital
02/10/22 Colliers
Knowles upgraded to Buy from Neutral at Colliers
KN Knowles
$14.67 /

-0.44 (-2.91%)

KN Knowles
$14.67 /

-0.44 (-2.91%)

Conference/Events
Evelo Biosciences to host conference call » 17:32
11/28/22
11/28
17:32
11/28/22
17:32
EVLO

Evelo Biosciences

$2.01 /

+0.065 (+3.34%)

Chief Scientific Officer…

Chief Scientific Officer Bodmer discusses SINTAX medicines and the potential to treat inflammatory disease on a conference call to be held on November 30 at 8 am. Webcast Link

ShowHide Related Items >><<
EVLO Evelo Biosciences
$2.01 /

+0.065 (+3.34%)

EVLO Evelo Biosciences
$2.01 /

+0.065 (+3.34%)

11/16/22 Chardan
Evelo Biosciences downgraded to Neutral from Buy at Chardan
08/15/22 Chardan
Evelo Biosciences price target lowered to $5 from $12 at Chardan
EVLO Evelo Biosciences
$2.01 /

+0.065 (+3.34%)

Conference/Events
Allogene Therapeutics to hold a research and development showcase » 17:27
11/28/22
11/28
17:27
11/28/22
17:27
ALLO

Allogene Therapeutics

$10.27 /

-0.515 (-4.78%)

Research &…

Research & Development Showcase to be held in New York on November 29 at 1 pm. Webcast Link

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$10.27 /

-0.515 (-4.78%)

ALLO Allogene Therapeutics
$10.27 /

-0.515 (-4.78%)

11/21/22 H.C. Wainwright
Allogene Therapeutics price target lowered to $29 from $43 at H.C. Wainwright
09/22/22 B. Riley
Allogene Therapeutics price target lowered to $18 from $21 at B. Riley
09/20/22 B. Riley
B. Riley replaces Allogene with Syndax as top pick for 2022
08/10/22 Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
ALLO Allogene Therapeutics
$10.27 /

-0.515 (-4.78%)

ALLO Allogene Therapeutics
$10.27 /

-0.515 (-4.78%)

Hot Stocks
PBF Energy to replace Nu Skin in the S&P 400 at open on 12/1 » 17:21
11/28/22
11/28
17:21
11/28/22
17:21
PBF

PBF Energy

$42.85 /

-3.4 (-7.35%)

, NUS

Nu Skin

$39.99 /

+1.2 (+3.09%)

S&P SmallCap 600…

S&P SmallCap 600 constituent PBF Energy (PBF) will replace Nu Skin Enterprises (NUS) in the S&P MidCap 400, and Nu Skin Enterprises will replace PBF Energy in the S&P SmallCap 600. PBF is more representative of the mid-cap market space, and Nu Skin is more representative of the small-cap market space.

ShowHide Related Items >><<
PBF PBF Energy
$42.85 /

-3.4 (-7.35%)

PBF PBF Energy
$42.85 /

-3.4 (-7.35%)

11/09/22 Piper Sandler
PBF Energy price target raised to $69 from $53 at Piper Sandler
10/06/22 Piper Sandler
PBF Energy price target raised to $53 from $49 at Piper Sandler
09/23/22 Piper Sandler
PBF Energy price target raised to $49 from $45 at Piper Sandler
09/21/22 JPMorgan
PBF Energy upgraded to Overweight from Neutral at JPMorgan
NUS Nu Skin
$39.99 /

+1.2 (+3.09%)

11/23/22 DA Davidson
Nu Skin price target lowered to $34 from $40 at DA Davidson
11/04/22 Citi
Nu Skin price target lowered to $35 from $39 at Citi
10/21/22 Jefferies
Nu Skin transferred with a Buy at Jefferies
10/05/22 Citi
Nu Skin price target lowered to $39 from $47 at Citi
PBF PBF Energy
$42.85 /

-3.4 (-7.35%)

NUS Nu Skin
$39.99 /

+1.2 (+3.09%)

PBF PBF Energy
$42.85 /

-3.4 (-7.35%)

NUS Nu Skin
$39.99 /

+1.2 (+3.09%)

Hot Stocks
Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 » 17:20
11/28/22
11/28
17:20
11/28/22
17:20
SABR

Sabre

$5.45 /

+0.11 (+2.06%)

, FBC

Flagstar Bancorp

$37.14 /

-0.86 (-2.26%)

Nexstar Media Group…

Nexstar Media Group (NXST) will replace Sabre Corp. (SABR) in the S&P MidCap 400, and Sabre will replace Flagstar Bancorp (FBC) in the S&P SmallCap 600. S&P MidCap 400 constituent New York Community Bancorp (NYCB) is acquiring Flagstar Bancorp in a deal expected to be completed soon pending final conditions. Sabre has a market capitalization more representative of the small-cap market space.

ShowHide Related Items >><<
SABR Sabre
$5.45 /

+0.11 (+2.06%)

FBC Flagstar Bancorp
$37.14 /

-0.86 (-2.26%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

10/17/22 Mizuho
Sabre price target lowered to $6 from $7 at Mizuho
09/28/22 Redburn
Sabre initiated with a Buy at Redburn
09/08/22 Mizuho
Sabre price target lowered to $7 from $8 at Mizuho
08/22/22 Mizuho
Sabre price target raised to $8 from $7 at Mizuho
FBC Flagstar Bancorp
$37.14 /

-0.86 (-2.26%)

07/11/22 B. Riley
Flagstar Bancorp price target lowered to $40 from $44 at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/02/22 Keefe Bruyette
New York Community downgraded to Market Perform at Keefe Bruyette
SABR Sabre
$5.45 /

+0.11 (+2.06%)

FBC Flagstar Bancorp
$37.14 /

-0.86 (-2.26%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

FBC Flagstar Bancorp
$37.14 /

-0.86 (-2.26%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

Hot Stocks
Nexstar to replace Sabre in the S&P 400 at open on 12/1 » 17:19
11/28/22
11/28
17:19
11/28/22
17:19
NXST

Nexstar

$174.69 /

-1.6 (-0.91%)

, SABR

Sabre

$5.45 /

+0.11 (+2.06%)

Nexstar Media Group…

Nexstar Media Group (NXST) will replace Sabre Corp. (SABR) in the S&P MidCap 400, and Sabre will replace Flagstar Bancorp (FBC) in the S&P SmallCap 600. S&P MidCap 400 constituent New York Community Bancorp (NYCB) is acquiring Flagstar Bancorp in a deal expected to be completed soon pending final conditions. Sabre has a market capitalization more representative of the small-cap market space.

ShowHide Related Items >><<
SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

11/11/22 Barrington
Nexstar price target lowered to $200 from $240 at Barrington
11/09/22 Wells Fargo
Nexstar downgraded to Equal Weight from Overweight at Wells Fargo
10/06/22
Nexstar participates in a conference call with Benchmark
09/06/22 Rosenblatt
Nexstar upgraded to Buy from Neutral at Rosenblatt
SABR Sabre
$5.45 /

+0.11 (+2.06%)

10/17/22 Mizuho
Sabre price target lowered to $6 from $7 at Mizuho
09/28/22 Redburn
Sabre initiated with a Buy at Redburn
09/08/22 Mizuho
Sabre price target lowered to $7 from $8 at Mizuho
08/22/22 Mizuho
Sabre price target raised to $8 from $7 at Mizuho
SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

NXST Nexstar
$174.69 /

-1.6 (-0.91%)

SABR Sabre
$5.45 /

+0.11 (+2.06%)

Conference/Events
CBRE Group management to meet with BMO Capital » 17:18
11/28/22
11/28
17:18
11/28/22
17:18
CBRE

CBRE Group

$75.15 /

-1.91 (-2.48%)

Leasing discussion with…

Leasing discussion with Chairman Amrich of CBRE's NYC Advisory & Transaction Services Group to be held at a meeting in New York on November 29 at 10 am hosted by BMO Capital.

ShowHide Related Items >><<
CBRE CBRE Group
$75.15 /

-1.91 (-2.48%)

CBRE CBRE Group
$75.15 /

-1.91 (-2.48%)

09/21/22 UBS
CBRE Group price target lowered to $86 from $95 at UBS
07/22/22 Raymond James
Cushman & Wakefield removed from Analyst Current Favorites list at Raymond James
07/22/22 Raymond James
CBRE Group added to Analyst Current Favorites list at Raymond James
07/22/22 Raymond James
CBRE Group upgraded to Strong Buy from Outperform at Raymond James
CBRE CBRE Group
$75.15 /

-1.91 (-2.48%)

CBRE CBRE Group
$75.15 /

-1.91 (-2.48%)

Hot Stocks
Raytheon Technologies awarded $397.68M Navy contract modification » 17:17
11/28/22
11/28
17:17
11/28/22
17:17
RTX

Raytheon Technologies

$96.95 /

-0.62 (-0.64%)

Raytheon was awarded a…

Raytheon was awarded a $397.68M firm-fixed-price modification to a previously awarded contract to exercise options for FY23 guided missile assemblies, shipping containers, and spare parts in support of the FY21-FY23 Evolved Seasparrow Missile Block 2 full-rate production requirements. Work is expected to be completed by March 2027. FY23 other customer funds in the amount of $214.45M; FY23 weapon procurement funds in the amount of $163.32M; FY20 other customer funds in the amount of $8.75M; FY21 other customer funds in the amount of $7.23M; FY19 other customer funds in the amount of $1.31M; FY22 other customer funds in the amount of $1.25M; FY22 weapons procurement funds in the amount of $824.92M and FY21 weapons procurement funds in the amount of $538,000, will be obligated at time of award and $538,000 will expire at the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

11/28/22 Cowen
Raytheon Technologies a Best Idea for 2023, says Cowen
10/26/22 Morgan Stanley
Raytheon Technologies price target lowered to $119 from $124 at Morgan Stanley
10/26/22 Baird
Raytheon Technologies price target lowered to $106 from $117 at Baird
10/11/22 Credit Suisse
Raytheon initiated with Neutral on estimate risk at Credit Suisse
RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

RTX Raytheon Technologies
$96.95 /

-0.62 (-0.64%)

Conference/Events
Emerson Electric to host virtual investor meeting » 17:13
11/28/22
11/28
17:13
11/28/22
17:13
EMR

Emerson Electric

$94.16 /

-1.99 (-2.07%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on November 29 at 9 am. Webcast Link

ShowHide Related Items >><<
EMR Emerson Electric
$94.16 /

-1.99 (-2.07%)

EMR Emerson Electric
$94.16 /

-1.99 (-2.07%)

11/16/22 Oppenheimer
Emerson Electric price target raised to $115 from $105 at Oppenheimer
11/01/22 Deutsche Bank
Emerson Electric downgraded on lack of catalysts at Deutsche Bank
11/01/22 Deutsche Bank
Emerson Electric downgraded to Hold from Buy at Deutsche Bank
10/13/22 Deutsche Bank
Emerson Electric price target lowered to $97 from $99 at Deutsche Bank
EMR Emerson Electric
$94.16 /

-1.99 (-2.07%)

EMR Emerson Electric
$94.16 /

-1.99 (-2.07%)

EMR Emerson Electric
$94.16 /

-1.99 (-2.07%)

Hot Stocks
Canadian National appoints Edmond Harris COO » 17:04
11/28/22
11/28
17:04
11/28/22
17:04
CNI

Canadian National

$126.01 /

-0.9 (-0.71%)

CN announced the…

CN announced the appointment of Edmond Harris as executive VP and COO. Harris succeeds Rob Reilly, effective immediately. Since April 2022, Harris, a highly respected industry veteran, has worked closely with the entire CN operations leadership team on the company's operational and service excellence initiatives, as the team delivered meaningful rail operations performance and customer service improvements. Prior to joining CN in a consulting capacity earlier this year, Harris served as executive VP, Operations, at CSX from 2018 to 2020. He also previously served as COO of Canadian Pacific Railway from 2010 to 2012.

ShowHide Related Items >><<
CNI Canadian National
$126.01 /

-0.9 (-0.71%)

CNI Canadian National
$126.01 /

-0.9 (-0.71%)

10/26/22 BMO Capital
Canadian National price target raised to C$180 from C$170 at BMO Capital
10/26/22 Scotiabank
Canadian National price target raised to C$159 from C$156 at Scotiabank
10/26/22 Barclays
Canadian National price target raised to $118 from $110 at Barclays
10/17/22 Stifel
Canadian National price target lowered to $118 from $119 at Stifel
CNI Canadian National
$126.01 /

-0.9 (-0.71%)

CNI Canadian National
$126.01 /

-0.9 (-0.71%)

CNI Canadian National
$126.01 /

-0.9 (-0.71%)

Hot Stocks
Ichor Holdings names Bruce Ragsdale COO » 17:00
11/28/22
11/28
17:00
11/28/22
17:00
ICHR

Ichor Holdings

$26.72 /

-1.575 (-5.57%)

Ichor Holdings announced…

Ichor Holdings announced the appointment of Bruce Ragsdale as the company's new chief operating officer, effective December 12, 2022. Ragsdale will be responsible for overseeing Ichor's global operations and supply chain. "We are very pleased to welcome Bruce Ragsdale to Ichor as our new COO," said Jeff Andreson, CEO. "Bruce brings nearly 30 years of manufacturing, engineering, and supply chain experience in the semiconductor capital equipment industry. He has a stellar track record of operational excellence at both Applied Materials and ASM International, and has a wealth of experience around the globe that will enable him to make valuable contributions toward the execution of our operational and financial objectives." Ragsdale most recently served as vice president, supply chain sourcing at Intel Corporation.

ShowHide Related Items >><<
ICHR Ichor Holdings
$26.72 /

-1.575 (-5.57%)

10/04/22 B. Riley
Ichor Holdings price target lowered to $32 from $33 at B. Riley
08/10/22 B. Riley
Ichor Holdings price target raised to $33 from $30 at B. Riley
08/10/22 Cowen
Ichor Holdings price target lowered to $36 from $41 at Cowen
06/15/22 B. Riley
B. Riley downgrades eight semi stocks on 'demand destruction risk'
ICHR Ichor Holdings
$26.72 /

-1.575 (-5.57%)

ICHR Ichor Holdings
$26.72 /

-1.575 (-5.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.